EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SIU-ICUD: Epidemiology of Prostate Cancer

Bárbara Vieira Lima Aguiar Melão, Kelly R. Pekala, Konstantina Matsoukas, Ola Bratt, Sigrid V. Carlsson

Société Internationale d’Urologie Journal · 12.06.2025 · 6 (3) · 44

DOI: 10.3390/siuj6030044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Société Internationale d’Urologie Journal, online erschienen am 12.06.2025. Verfasst von Bárbara Vieira Lima Aguiar Melão und 4 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health/National Cancer Institute, CAPES Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Prostate cancer (PCa) is the second most common malignancy among men worldwide and a leading cause of cancer-related mortality. In 2022, over 1.4 million new cases were reported globally, with a prevalence exceeding 5 million. Despite its widespread occurrence, the incidence and mortality of PCa show substantial geographic variation, influenced by factors such as genetic predisposition, healthcare access, lifestyle, and the adoption of screening programs. Regions with high PCa incidence, such as Northern America and Oceania, often have lower mortality rates due to early detection and advanced healthcare infrastructure. Conversely, areas with limited access to medical resources, such as parts of Africa and Latin America, experience higher mortality rates.

Methods

This review explores non-modifiable risk factors such as age, family history, and race, emphasizing their role in PCa development and progression.

Results

Modifiable factors, including diet, physical activity, alcohol consumption, and smoking, are also addressed, with evidence suggesting their potential in mitigating risk. Emerging data on medications such as 5-alpha reductase inhibitors and statins, as well as dietary supplements such as vitamins D, indicate their potential for chemoprevention, though further research is needed to solidify these findings. Healthcare disparities, especially in low- and middle-income regions, highlight the need for equitable access to diagnostic tools and treatment options. The review underscores the significance of tailored screening approaches, particularly in high-risk populations, to optimize outcomes while minimizing overdiagnosis and overtreatment.

Conclusions

The review concludes with recommendations for future research, including the need for standardized screening protocols and the exploration of novel biomarkers for early detection. By synthesizing epidemiological data and current evidence, this review aims to enhance understanding of PCa risk factors, geographic disparities, and preventive strategies, ultimately contributing to improved global PCa management and outcomes.

Förderung

  • National Institutes of Health/National Cancer Institute
  • CAPES Foundation

Zitieren

APA

Melão, B. V. L. A., Pekala, K. R., Matsoukas, K., Bratt, O., & Carlsson, S. V. (2025). SIU-ICUD: Epidemiology of Prostate Cancer. Société Internationale d’Urologie Journal, 6(3), 44. https://doi.org/10.3390/siuj6030044

Vancouver

Melão BVLA, Pekala KR, Matsoukas K, Bratt O, Carlsson SV. SIU-ICUD: Epidemiology of Prostate Cancer. Société Internationale d’Urologie Journal. 2025;6(3):44. doi:10.3390/siuj6030044

BibTeX
@article{Melo2025,
  author = {Melão, Bárbara Vieira Lima Aguiar and Pekala, Kelly R. and Matsoukas, Konstantina and Bratt, Ola and Carlsson, Sigrid V.},
  title = {SIU-ICUD: Epidemiology of Prostate Cancer},
  journal = {Société Internationale d’Urologie Journal},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {44},
  doi = {10.3390/siuj6030044}
}
Kostenlos starten →